These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23086793)

  • 1. Vascular responses to a biodegradable polymer (polylactic acid) based biolimus A9-eluting stent in porcine models.
    Hagiwara H; Hiraishi Y; Terao H; Hirai T; Sakaoka A; Sasaki M; Murota S; Inoue K; Kimura J
    EuroIntervention; 2012 Oct; 8(6):743-51. PubMed ID: 23086793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evaluation of a biolimus eluting nickel titanium self expanding stent with overlapping balloon expandable drug eluting and bare metal stents in a porcine coronary model.
    Cilingiroglu M; Elliott J; Sangi P; Matthews H; Tio F; Trauthen B; Elicker J; Bailey SR
    EuroIntervention; 2009 Jan; 4(4):534-41. PubMed ID: 19284078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term coronary arterial response to biodegradable polymer biolimus-eluting stents in comparison with durable polymer sirolimus-eluting stents and bare-metal stents: five-year follow-up optical coherence tomography study.
    Kuramitsu S; Sonoda S; Yokoi H; Iwabuchi M; Nishizaki Y; Shinozaki T; Domei T; Hyodo M; Inoue K; Shirai S; Ando K; Nobuyoshi M
    Atherosclerosis; 2014 Nov; 237(1):23-9. PubMed ID: 25190308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo comparison of a polymer-free Biolimus A9-eluting stent with a biodegradable polymer-based Biolimus A9 eluting stent and a bare metal stent in balloon denuded and radiated hypercholesterolemic rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Seabron R; Hellinga D; Chan R; Su SH; Kolodgie F; Virmani R
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):429-36. PubMed ID: 22105925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological comparison of biodegradable polymer and permanent polymer based sirolimus eluting stents in a porcine model of coronary stent implantation.
    Koppara T; Joner M; Bayer G; Steigerwald K; Diener T; Wittchow E
    Thromb Haemost; 2012 Jun; 107(6):1161-71. PubMed ID: 22535188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review.
    Ahmed TA; Bergheanu SC; Stijnen T; Plevier JW; Quax PH; Jukema JW
    EuroIntervention; 2011 Aug; 7(4):505-16. PubMed ID: 21764670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential healing responses in polymer- and nonpolymer-based sirolimus-eluting stents.
    John MC; Wessely R; Kastrati A; Schömig A; Joner M; Uchihashi M; Crimins J; Lajoie S; Kolodgie FD; Gold HK; Virmani R; Finn AV
    JACC Cardiovasc Interv; 2008 Oct; 1(5):535-44. PubMed ID: 19463356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer-free biolimus a9-coated stent demonstrates more sustained intimal inhibition, improved healing, and reduced inflammation compared with a polymer-coated sirolimus-eluting cypher stent in a porcine model.
    Tada N; Virmani R; Grant G; Bartlett L; Black A; Clavijo C; Christians U; Betts R; Savage D; Su SH; Shulze J; Kar S
    Circ Cardiovasc Interv; 2010 Apr; 3(2):174-83. PubMed ID: 20407114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The three year follow-up of the randomised "all-comers" trial of a biodegradable polymer biolimus-eluting stent versus permanent polymer sirolimus-eluting stent (LEADERS).
    Wykrzykowska J; Serruys P; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Corti R; Wijns W; Morice MC; Di Mario C; Van Geuns RJ; Van Es GA; Juni P; Windecker S
    EuroIntervention; 2011 Nov; 7(7):789-95. PubMed ID: 22027687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular healing in drug-eluting stents: differential drug-associated response of limus-eluting stents in a preclinical model of stent implantation.
    Steigerwald K; Ballke S; Quee SC; Byrne RA; Vorpahl M; Vogeser M; Kolodgie F; Virmani R; Joner M
    EuroIntervention; 2012 Oct; 8(6):752-9. PubMed ID: 23086794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteries.
    Sperling C; Waliszewski MW; Kherad B; Krackhardt F
    Ther Adv Cardiovasc Dis; 2019; 13():1753944719826335. PubMed ID: 30803407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-year clinical follow-up from the randomized comparison of biolimus-eluting stents with biodegradable polymer and sirolimus-eluting stents with durable polymer in routine clinical practice.
    Klauss V; Serruys PW; Pilgrim T; Buszman P; Linke A; Ischinger T; Eberli F; Corti R; Wijns W; Morice MC; di Mario C; van Geuns RJ; van Es GA; Kalesan B; Wenaweser P; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2011 Aug; 4(8):887-95. PubMed ID: 21851904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model.
    Nakazawa G; Shinke T; Ijichi T; Matsumoto D; Otake H; Torii S; Hiranuma N; Ohsue T; Otsuka F; Shite J; Hirata K; Ikari Y
    EuroIntervention; 2014 Oct; 10(6):717-23. PubMed ID: 25330504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy.
    Wykrzykowska JJ; Serruys PW; Onuma Y; de Vries T; van Es GA; Buszman P; Linke A; Ischinger T; Klauss V; Corti R; Eberli F; Wijns W; Morice MC; di Mario C; van Geuns RJ; Juni P; Windecker S
    JACC Cardiovasc Interv; 2009 Sep; 2(9):861-70. PubMed ID: 19778775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular response and mechanical integrity of the new biodegradable polymer coated sirolimus-eluting PROLIM stent implanted in porcine coronary arteries.
    Milewski K; Gorycki B; Buszman PP; Jelonek M; Beaudry D; Lapointe JM; Guy LG; Abusamra M; Pająk J; Kinasz W; Wojakowski W; Leclerc G; Gil RJ; Buszman PE
    Kardiol Pol; 2012; 70(7):703-11. PubMed ID: 22825946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymer-free dual drug-eluting stents evaluated in a porcine model.
    Zhang B; Zheng B; Wang X; Shi Q; Jia J; Huo Y; Pan C; Han J; Chen M
    BMC Cardiovasc Disord; 2017 Aug; 17(1):222. PubMed ID: 28810900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of an asymmetrical coating stent with sirolimus released from ablumial matrix in porcine model.
    Shen L; Wu Y; Zhang F; Wu L; Dong C; Gao Y; Sun A; Zou Y; Qian J; Sun J; Zhong W; Ge J
    Clin Res Cardiol; 2012 Nov; 101(11):917-27. PubMed ID: 22627890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial.
    Räber L; Kelbæk H; Taniwaki M; Ostojic M; Heg D; Baumbach A; von Birgelen C; Roffi M; Tüller D; Engstrøm T; Moschovitis A; Pedrazzini G; Wenaweser P; Kornowski R; Weber K; Lüscher TF; Matter CM; Meier B; Jüni P; Windecker S;
    Circ Cardiovasc Interv; 2014 Jun; 7(3):355-64. PubMed ID: 24847017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.